UNIVERSITY COLLEGE LONDON (UCL)
The UCL Institute of Immunity & Transplantation (IIT) is an international centre of excellence in immunology research. The IIT is a hub for experimental medicine, transferring novel research concepts into new diagnostic tools and therapeutic interventions for the local and global patient population. Its multidisciplinary research and training programs serve to educate scientists and health professionals. Through joint working, IIT accelerates the implementation of novel immunotherapies as routine treatment. The IIT aims to develop vaccinations, gene therapy and cell therapy to enhance immunity in patients with cancer and chronic infection, and to induce tolerance in autoimmune diseases and in patients receiving conventional or bioengineered transplants. The research activities of the IIT are grouped in three research clusters, with each cluster containing two related programs of research: 1) Immune tolerance,
2) Immunotherapy, 3) Inherited disease.
Role in TherVacB
UCL contributes to Immune Monitoring and Biomarker Evaluation, with exploratory immunological assays to shed light on immune constraints (particularly on B cells) that could be targeted for optimisation of the response to therapeutic vaccination in future trials.
Specialized in HBV Immunology and Immunotherapy.